CRISPR-mediated upregulation of DR5 and downregulation of cFLIP synergistically sensitize HeLa cells to TRAIL-mediated apoptosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CRISPR-mediated upregulation of DR5 and downregulation of cFLIP synergistically sensitize HeLa cells to TRAIL-mediated apoptosis

Published:2019-04 Issue:1 Volume:512 Page:60-65
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Poondla Naresh,Chandrasekaran Arun Pandian,Heese Klaus^ORCID,Kim Kye-Seong,Ramakrishna Suresh^ORCID

Funder

National Research Foundation of Korea

Medical Research Center

Ministry of Science, ICT and Future Planning, Republic of Korea

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference28 articles.

1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

2. Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/tumor necrosis factor–related apoptosis-inducing ligand (rhApo2L/TRAIL);Ashkenazi;J. Clin. Oncol.,2008

3. New insights into apoptosis signaling by Apo2L/TRAIL;Gonzalvez;Oncogene,2010

4. c-Jun NH 2 -terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells;Zou;Cancer Res.,2004

5. Targeting the extrinsic apoptosis pathway in cancer;Ashkenazi;Cytokine Growth Factor Rev.,2008

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MAP kinase ERK5 modulates cancer cell sensitivity to extrinsic apoptosis induced by death-receptor agonists;Cell Death & Disease;2023-11-02

2. Recent progress in apoptosis triggering facilitated by HeLa Studies;Acta Marisiensis - Seria Medica;2023-06-01

3. MAP kinase ERK5 modulates cancer cell sensitivity to extrinsic apoptosis induced by death-receptor agonists and Natural Killer cells;2023-03-24

4. Advances in CRISPR therapeutics;Nature Reviews Nephrology;2022-10-24

5. Characterizing genes associated with cancer using the CRISPR/Cas9 system: A systematic review of genes and methodological approaches;Gene;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3